Physician profile
Michael M Henry
NPI 1609839844
$32,725.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,284 · 2020: $31.35 · 2021: $22K · 2022: $4,613 · 2023: $379 · 2024: $1,446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,320 · Food and Beverage: $424 · Education: $80.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,320.00 |
| Food and Beverage | $424.20 |
| Education | $80.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $32,000.23 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $250.00 | 2022 | |
| Genzyme Corporation | $154.07 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $135.32 | 2023 | |
| Zimmer Biomet Holdings, INC. | $126.24 | 2024 | Affixus |
| Abbvie INC. | $28.20 | 2022 | |
| Abbott Laboratories | $20.38 | 2020 | |
| Paratek Pharmaceuticals, INC. | $10.97 | 2020 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.